UGCG

Revision as of 15:42, 6 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


UDP-glucose ceramide glucosyltransferase
Identifiers
Symbols UGCG ; GCS
External IDs Template:OMIM5 Template:MGI HomoloGene37763
RNA expression pattern
File:PBB GE UGCG 204881 s at tn.png
File:PBB GE UGCG 221765 at tn.png
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

UDP-glucose ceramide glucosyltransferase, also known as UGCG, is a human gene.[1]

Glycosphingolipids (GSLs) are a group of membrane components that contain lipid and sugar moieties. They are present in essentially all animal cells and are believed to have important roles in various cellular processes. UDP-glucose ceramide glucosyltransferase catalyzes the first glycosylation step in glycosphingolipid biosynthesis. The product, glucosylceramide, is the core structure of more than 300 GSLs. UGCG is widely expressed and transcription is upregulated during keratinocyte differentiation.[1]

References

  1. 1.0 1.1 "Entrez Gene: UGCG UDP-glucose ceramide glucosyltransferase".

Further reading

  • Kohyama-Koganaya A, Hirabayashi Y (2002). "[Role of glucosylceramide synthase as negative regulator for ceramide]". Tanpakushitsu Kakusan Koso. 47 (4 Suppl): 470–5. PMID 11915344.
  • Matsuo N, Nomura T, Imokawa G (1992). "A rapid and simple assay method for UDP-glucose:ceramide glucosyltransferase". Biochim. Biophys. Acta. 1116 (2): 97–103. PMID 1533793.
  • Ichikawa S, Sakiyama H, Suzuki G; et al. (1996). "Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis". Proc. Natl. Acad. Sci. U.S.A. 93 (10): 4638–43. PMID 8643456.
  • Ichikawa S, Sakiyama H, Suzuki G; et al. (1996). "Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis". Proc. Natl. Acad. Sci. U.S.A. 93 (22): 12654. PMID 8901638.
  • Watanabe R, Wu K, Paul P; et al. (1998). "Up-regulation of glucosylceramide synthase expression and activity during human keratinocyte differentiation". J. Biol. Chem. 273 (16): 9651–5. PMID 9545298.
  • Ichikawa S, Ozawa K, Hirabayashi Y (1998). "Assignment of a UDP-glucose:ceramide glucosyltransferase gene (UGCG) to human chromosome band 9q31 by in situ hybridization". Cytogenet. Cell Genet. 79 (3–4): 233–4. PMID 9605861.
  • Tepper AD, Diks SH, van Blitterswijk WJ, Borst J (2000). "Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens". J. Biol. Chem. 275 (44): 34810–7. doi:10.1074/jbc.M005142200. PMID 10945987.
  • Ogretmen B, Schady D, Usta J; et al. (2001). "Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells". J. Biol. Chem. 276 (27): 24901–10. doi:10.1074/jbc.M100314200. PMID 11335714.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Di Sano F, Fazi B, Citro G; et al. (2003). "Glucosylceramide synthase and its functional interaction with RTN-1C regulate chemotherapeutic-induced apoptosis in neuroepithelioma cells". Cancer Res. 63 (14): 3860–5. PMID 12873973.
  • Grazide S, Terrisse AD, Lerouge S; et al. (2004). "Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines". J. Biol. Chem. 279 (18): 18256–61. doi:10.1074/jbc.M314105200. PMID 14766899.
  • Norris-Cervetto E, Callaghan R, Platt FM; et al. (2004). "Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells". J. Biol. Chem. 279 (39): 40412–8. doi:10.1074/jbc.M404466200. PMID 15263008.
  • Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
  • Turzanski J, Grundy M, Shang S; et al. (2005). "P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway". Exp. Hematol. 33 (1): 62–72. doi:10.1016/j.exphem.2004.10.005. PMID 15661399.
  • Sun NN, Fastje CD, Wong SS; et al. (2005). "Dose-dependent transcriptome changes by metal ores on a human acute lymphoblastic leukemia cell line". Toxicology and industrial health. 19 (7–10): 157–63. PMID 15747776.
  • Rual JF, Venkatesan K, Hao T; et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
  • Fazi B, Melino S, Di Sano F; et al. (2006). "Cloning, expression, and preliminary structural characterization of RTN-1C". Biochem. Biophys. Res. Commun. 342 (3): 881–6. doi:10.1016/j.bbrc.2006.02.036. PMID 16500619.

Template:WikiDoc Sources